Titan Medical Inc. (TMD.TO)
CAD 1.13
(2150.0%)
CAD 1.13
(2150.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 17.63 Million | - | 20.09 Million | 20 Million | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | 17.63 Million | - | 20.09 Million | 20 Million | - | - |
| Operating Expenses | 8.68 Million | 42.59 Million | 51.08 Million | 15.8 Million | 59.26 Million | 39.69 Million |
| Selling, General and Administrative Expenses | 8.36 Million | 11.48 Million | 12.42 Million | 7.62 Million | 7.81 Million | 6.8 Million |
| Research and Development Expenses | 321 Thousand | 33 Million | 37.95 Million | 7.93 Million | 51.41 Million | 32.85 Million |
| Other Expenses | 1.31 Million | - | 699 Thousand | 236.84 Thousand | 32.55 Thousand | - |
| Cost and Expenses | 8.68 Million | 42.59 Million | 51.08 Million | 15.8 Million | 59.26 Million | 39.69 Million |
| Operating Income | 4.83 Million | -44.48 Million | -30.98 Million | 2.94 Million | -61.24 Million | -54.17 Million |
| Interest Expense | 221 Thousand | - | 125 Thousand | 1.09 Million | 422.98 Thousand | - |
| Income Tax Expense | 24 Thousand | 56 Thousand | 56 Thousand | 1.09 Million | 422.98 Thousand | -17.05 Million |
| Earnings before Tax | 6.97 Million | -42.59 Million | -14.8 Million | -24.18 Million | -41.9 Million | -22.63 Million |
| Net Income | 6.95 Million | -42.54 Million | -14.85 Million | -25.27 Million | -42.33 Million | -22.63 Million |
| Earnings Per Share Basic | 0.06 | -0.38 | -0.14 | -0.38 | -1.38 | -1.36 |
| Earnings Per Share Diluted | 0.06 | -0.38 | -0.14 | -0.38 | -1.38 | -1.36 |
| Weighted Average Shares Outstanding | 113.09 Million | 111.52 Million | 106.12 Million | 67 Million | 30.58 Million | 16.63 Million |
| Weighted Average Shares Outstanding (Diluted) | 116.84 Million | 111.52 Million | 108.44 Million | 67 Million | 30.68 Million | 16.63 Million |
| Gross Margin | 1.00 | - | 1.00 | 1.00 | - | - |
| EBIT Margin | 0.61 | - | -1.47 | 0.13 | - | - |
| Profit Margin | 0.39 | - | -0.74 | -1.26 | - | - |
| EBITDA | 10.54 Million | -44.03 Million | -29.61 Million | 2.64 Million | -59.23 Million | -57.73 Million |
| Earnings Before Tax Margin | 0.27 | - | -1.54 | 0.15 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 17.63 Million | 500 Thousand | 450 Thousand | 16.68 Million |
| Cost of Revenue | - | - | - | - | - | 1.00 |
| Gross Profit | - | - | 17.63 Million | 500 Thousand | 450 Thousand | 16.68 Million |
| Operating Expenses | 1.1 Million | 840 Thousand | 8.68 Million | 66 Thousand | 1.22 Million | 4.64 Million |
| Selling, General and Administrative Expenses | 1.1 Million | 943 Thousand | - | 642 Thousand | 1.13 Million | 4.28 Million |
| Research and Development Expenses | - | 103 Thousand | - | -576 Thousand | 89 Thousand | 360 Thousand |
| Other Expenses | 8000.00 | - | 1.31 Million | 180 Thousand | 442 Thousand | 692 Thousand |
| Cost and Expenses | 1.1 Million | 840 Thousand | 8.68 Million | 66 Thousand | 1.22 Million | 4.64 Million |
| Operating Income | -1.1 Million | -840 Thousand | 4.83 Million | -3.67 Million | -775 Thousand | 12.03 Million |
| Interest Expense | 32 Thousand | 35 Thousand | 221 Thousand | 38 Thousand | 41 Thousand | 65 Thousand |
| Income Tax Expense | 3000.00 | -11.5 Thousand | 24 Thousand | 242 Thousand | 483 Thousand | 757 Thousand |
| Earnings before Tax | -1.06 Million | -807 Thousand | 6.97 Million | -3.21 Million | 68 Thousand | 12.69 Million |
| Net Income | -1.06 Million | -807 Thousand | 6.95 Million | -3.24 Million | 68 Thousand | 13.25 Million |
| Earnings Per Share Basic | -0.01 | -0.01 | - | -0.03 | 0.00 | 0.11 |
| Earnings Per Share Diluted | -0.01 | -0.01 | - | -0.03 | 0.00 | 0.09 |
| Weighted Average Shares Outstanding | 114.03 Million | 114.03 Million | 113.09 Million | 112.4 Million | 129.1 Million | 135.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 114.03 Million | 114.03 Million | 116.84 Million | 113.91 Million | 129.1 Million | 135.8 Million |
| Gross Margin | - | - | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | - | - | - | 1.62 | -0.28 | 0.77 |
| Profit Margin | - | - | 0.39 | -6.49 | 0.15 | 0.79 |
| EBITDA | -1.02 Million | -740 Thousand | - | 809 Thousand | -128 Thousand | 12.78 Million |
| Earnings Before Tax Margin | - | - | 0.27 | -7.35 | -1.72 | 0.72 |
CHSCN
GCB
PSPPROJECT
2217
0331
STEM